India's Richest People 2026 edition · 1 director · Source: Hurun India
- #1,233 Arpit Janmejay Vyas ₹1,900 Cr
Revenue · FY 2025
₹27.14 Cr
▲ 237% YoY
Net profit · FY 2025
₹30 Lakh
Net margin 1.1%
EBITDA · FY 2025
₹5.73 Cr
EBITDA margin 21.1%
Authorised capital
₹6.5 Cr
Registered with MCA
Paid-up capital
₹6.5 Cr
Issued & subscribed
Open charges
₹163 Cr
Satisfied ₹128.41 Cr
Company age
31 yrs
Est. 1995
Employees · EPFO
17
Provident fund records
About Dishman Biotech Limited
Data last updated:
Dishman Biotech Limited is a public limited company based in Ahmedabad, Gujarat, India, a subsidiary of Dishman Carbogen Amcis Limited. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 08 November 1995 and has been in existence for over 31 years.
Its director Arpit Janmejay Vyas is #1,233 among India's richest people (2026).
The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24231GJ1995PLC028060. Its GSTIN is 24AACCS0988C1ZJ (Gujarat).
The company has an authorised share capital of ₹6.5 Cr and a paid-up capital of ₹6.5 Cr. It was formerly known as Schutz Dishman Biotech Limited and Schutz Dishman Biotech Private Limited. It is led by directors including Deohooti Janmejay Vyas and Aditi Janmejay Vyas.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Dishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058.
As per the financials filed for FY 2025, the company reported a revenue of ₹27.14 Cr, reflecting significant growth compared to the previous year. For the same year it recorded a net profit of ₹30 Lakh (net margin 1.1%) and EBITDA of ₹5.73 Cr (EBITDA margin 21.1%). Revenue has grown at a compounded annual rate (CAGR) of 49% over three years and 4% over five years.
The company has about 17 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹163 Cr and satisfied charges of ₹128.41 Cr on record. Court records list 16 cases involving the company, including 16 filed against it; 5 cases are pending. The company has 1 deal on record (1 acquisition); the latest was in March 2016. Its 5 peer companies in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products) are compared by revenue, 3 larger and 2 smaller; the largest is Thakar Dass & Co Private Limited with revenue of ₹27.23 Cr. The company has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 20 micro and small suppliers.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website dishmangroup.com.
Company details
CIN U24231GJ1995PLC028060
Registration Number 028060
Incorporation Date 08 November 1995
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Parent Company Dishman Carbogen Amcis Limited
Compliance Status Active Compliant
Name history
Dishman Biotech has undergone 2 name changes throughout its history. The company was previously known as Schutz Dishman Biotech Limited, and Schutz Dishman Biotech Private Limited. The current legal name is Dishman Biotech Limited.
| Company Name | Status |
|---|---|
| Dishman Biotech Limited | Current |
| Schutz Dishman Biotech Limited | Previous |
| Schutz Dishman Biotech Private Limited | Previous |
Key People
Deohooti Janmejay Vyas Director Aditi Janmejay Vyas Director Arpit Janmejay Vyas Director Recognitions & Rankings of Dishman Biotech
Contact details
Dishman Biotech Limited's registered office is in Ahmedabad, Gujarat. Its website is dishmangroup.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered AddressDishman Corporate House Iscon – Bopal Road Ambli, Ahmedabad, Gujarat, India – 380058
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Dishman Biotech Limited, buy the company report.
Comprehensive company report
Dishman Biotech Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Dishman Biotech is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Dishman Biotech Limited, buy the company report.
Financials of Dishman Biotech Limited
FY 2025 filings availableDishman Biotech Limited reported revenue of ₹27.14 Cr (up 237% YoY) for FY 2025.
Revenue · FY 2025
₹27.14 Cr ▲ 237%
Net profit · FY 2025
₹30 Lakh margin 1.1%
EBITDA · FY 2025
₹5.73 Cr margin 21.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▲ 237%
3 years · compounded
▲ 49%
5 years · compounded
▲ 4%
EBITDA CAGR growth
1 year
▼ 23%
3 years · compounded
▼ 6%
5 years · compounded
▼ 11%
Revenue has grown at a compounded annual rate (CAGR) of 4% over five years, including 237% growth in the latest year. EBITDA fell 23% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹5.73 Cr | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹30 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 21.1% | ||||
| Net Profit Margin | 1.1% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Dishman Biotech Limited, buy the company report.
Board of directors of Dishman Biotech Limited
Dishman Biotech has 3 current directors and 6 former directors. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Deohooti Janmejay Vyas Also directs: Adimans Technologies LLP, Dishman Carbogen Amcis Limited, B R Laboratories Limited and 5 more | Director | 01 Dec 1997 | 28 Years 10 Months | Current |
| Aditi Janmejay Vyas Also directs: B R Laboratories Limited, Azafran Innovacion Limited, Dishman Infrastructure Limited and 3 more | Director | 01 Dec 1997 | 28 Years 10 Months | Current |
| Arpit Janmejay Vyas Also directs: Dishman Carbogen Amcis Limited, RTV Technochem Private Limited, Leon Hospitality Private Limited and 5 more | Director | 03 Jun 2009 | 17 Years 4 Months | Current |
Peer comparison
Dishman Biotech Limited is compared with the 5 companies closest to it by revenue in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Thakar Dass & Co Private Limited | ₹27.23 Cr (FY 2024) | 24.0% | New Delhi, Delhi, India | |||
| Vismita Intermediates Private Limited | ₹27.18 Cr (FY 2025) | 26.0% | Ankleshwar, Gujarat, India | |||
| Hind Suter Shellac Private Limited | ₹27.17 Cr (FY 2024) | -37.0% | Howrah, West Bengal, India | |||
| Dishman Biotech Limited this company | ₹27.14 Cr (FY 2025) | ₹30 Lakh | 1.1% | 237.0% | 17 | Ahmedabad, Gujarat, India |
| Bhabani Colors Private Limited | ₹27.09 Cr (FY 2025) | 18303.0% | Delhi, India | |||
| Kevy's Generics Private Limited | ₹26.72 Cr (FY 2024) | 9.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Dishman Biotech Limited, buy the company report.
Auditor
Dishman Biotech Limited is audited by Mukesh M. Shah & co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Mukesh M. Shah & co. | FY 2023 | 106625W |
Shareholding
The shareholding of Dishman Biotech Limited is on record for 5 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|
| Promoters | |||||
| Domestic institutional investors (DII) | |||||
| Foreign institutional investors (FII) | |||||
| Public | |||||
| Others |
To see the full shareholding pattern of Dishman Biotech Limited, buy the company report.
Charges & borrowings
Open charges
₹163 Cr
Satisfied charges
₹128.41 Cr
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 Sep 2025 | 101165974 | Others | ₹75 Cr | Open | |
| 26 Aug 2025 | 101147183 | Others | ₹25 Cr | Open | |
| 31 Jul 2025 | 101150594 | Others | ₹15 Cr | Open | |
| 31 Dec 2024 | 101047540 | Others | ₹10 Cr | Open | |
| 01 Apr 2024 | 100915027 | Others | ₹38 Cr | Open |
To see the full charge records of Dishman Biotech Limited, buy the company report.
Total charge records: 10 View all charges
Deals & funding
Dishman Biotech Limited has 1 deal on record (1 acquisition); the latest was in March 2016.
Total deals
1
Acquisition
1
Deals on record (1 of 1)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2016 | Acquisition | ₹2.26 Cr | Buyer: Dishman Pharmaceuticals and Chemicals Limited Seller: Schütz and Co. Beteiligungsgesellschaft mbH |
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal cases
Dishman Biotech Limited has 16 court cases on record: 16 filed against it. 5 cases are pending and 11 are disposed.
Total cases
16
Filed against the company
16
Pending
5
Disposed
11
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| High courts | 16 | 16 | 5 |
Cases on record (5 of 16)
| Court | Type of case | Party | Status |
|---|---|---|---|
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income Tax 4 | Pending |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by Principal Commissioner of Income Tax 4 | Pending |
| High Court of Gujarat | Court case (TAXAP) | Filed against the company by Pr.Commissioner of Income Tax-Iv | Pending |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income Tax-1 | Disposed |
| High Court, GUJARAT | Court case (TAXAP) | Filed against the company by The Principal Commissioner of Income Tax 4 | Disposed |
To see the full case history of Dishman Biotech Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
Dishman Biotech Limited has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 20 micro and small suppliers. Companies must report dues to micro and small suppliers that stay unpaid for more than 45 days in a half-yearly MSME Form 1 return.
Suppliers with reported dues (5 of 20)
| Supplier | Amount due | Due since | Reported on |
|---|---|---|---|
| Vijay Transtech Private Limited | |||
| an individual supplier | |||
| Target Sales | |||
| Novex Poly Films Private Limited | |||
| Sap Industries Limited |
To see the full MSME payment records of Dishman Biotech Limited, buy the company report.
Individuals and sole proprietors among the suppliers are not named.
Employees & EPFO
Dishman Biotech Limited has a workforce of 17 employees on its EPFO records as of Apr 02, 2024, across 1 active EPFO establishment.
Employee count
17
Active EPFO establishments
1
GST
Dishman Biotech has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AACCS0988C1ZJ | Gujarat | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Dishman Biotech Limited, buy the company report.
Recent activity
Dishman Biotech Limited has 9 board changes on record since 1997: 3 appointments and 6 cessations. The latest: Janmejay Rajnikant Vyas ceased to be Director on 27 May 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100330460 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100332685 with Others was fully satisfied on 12 Nov 2025.
Charges
A charge registered on 18 Feb 2020 via Charge ID 100330429 with Others was fully satisfied on 12 Nov 2025.
AGM
Dishman Biotech Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Others amounted to Rs. 75.00 Cr with Charge ID 101165974 was registered on 30 Sep 2025.
Charges
A charge with Others amounted to Rs. 25.00 Cr with Charge ID 101147183 was registered on 26 Aug 2025.
Charges
A charge with Others amounted to Rs. 15.00 Cr with Charge ID 101150594 was registered on 31 Jul 2025.
Ceased
Janmejay Rajnikant Vyas ceased to be Director.
Filing
Dishman Biotech Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Charges
A charge with Others amounted to Rs. 10.00 Cr with Charge ID 101047540 was registered on 31 Dec 2024.
Charges
A charge with Others amounted to Rs. 38.00 Cr with Charge ID 100915027 was registered on 01 Apr 2024.
Charges
A charge with Others of Rs. 40.73 Cr registered on 18 Feb 2020 with Charge ID 100330429 was modified on 15 Apr 2022.
18 earlier events are in the company report.
News
Frequently asked questions
Dishman Biotech is an active public limited company based in Ahmedabad, Gujarat, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 08 November 1995 (31+ years old) and is registered under CIN U24231GJ1995PLC028060.
Dishman Biotech has 3 current directors:
- Deohooti Janmejay Vyas - Director
- Aditi Janmejay Vyas - Director
- Arpit Janmejay Vyas - Director
The latest financial statements of Dishman Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Dishman Biotech is 24AACCS0988C1ZJ, registered in Gujarat.
The CIN (Corporate Identification Number) of Dishman Biotech is U24231GJ1995PLC028060. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Dishman Biotech has 16 court cases on record: 16 filed against it. 5 are pending.
Dishman Biotech was incorporated on 08 November 1995, making it 31+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Dishman Biotech has 1 deal on record (1 acquisition); the latest was in March 2016.
The peers of Dishman Biotech by revenue are Thakar Dass & Co Private Limited, Vismita Intermediates Private Limited, Hind Suter Shellac Private Limited, Bhabani Colors Private Limited, Kevy's Generics Private Limited, all in the Chemicals industry (Industrial Chemicals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Janmejay Rajnikant Vyas ceased to be Director on 27 May 2025. Katrin Adelheid Tiemann ceased to be Director on 01 Apr 2016. Reinhold Jakob Alt ceased to be Director on 01 Apr 2016. Dishman Biotech has 9 board changes on record in total.
Dishman Biotech has 3 MSME Form 1 returns on record between 2019 and 2020, listing 50 overdue payments to 20 micro and small suppliers. The latest return was filed on 05 Aug 2020.
Dishman Biotech can be reached through the website dishmangroup.com. Its registered office is in Ahmedabad, Gujarat, India.